Who owns Beam Therapeutics Inc (BEAM)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Beam Therapeutics Inc (BEAM) in their latest 13F filing, with $545.2M between them. Cathie Wood gives it the most weight: 1.66% of the reported portfolio. In their latest reported quarter, Stanley Druckenmiller opened a position; Cathie Wood and Andrew Spokes added.
Murray Stahl sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Cathie Wood, $288.6M
- Largest weight
- Cathie Wood, 1.66%of their portfolio
- Combined value
- $545.2M
- Bought last quarter
- 3
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Cathie WoodARK Invest | 1.66% | $288.6M | 11.81M | ▲ Added 15% | +1.57M | Q3 2026 |
| 2 | Andrew SpokesFarallon Capital Management | 1.31% | $251.3M | 10.28M | ▲ Added 0.4% | +39.92K | Q3 2026 |
| 3 | Stanley DruckenmillerDuquesne Family Office | 0.12% | $5.3M | 153.6K | New | +153.6K | Q2 2026 |
Sold out last quarter
- Murray Stahlwas $287.9K · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 22.08M | $539.9M | 2 | 1 |
| Q2 2026 | 157 | 3 | 20.62M | $707.8M | 2 | 1 |
| Q1 2026 | 157 | 2 | 22.27M | $530.6M | 1 | 1 |
| Q4 2025 | 157 | 2 | 22.53M | $624.5M | 1 | 1 |
| Q3 2025 | 157 | 2 | 21.1M | $512.1M | 2 | 1 |
| Q2 2025 | 157 | 2 | 18.86M | $320.8M | 2 | 1 |
| Q1 2025 | 156 | 3 | 20.22M | $394.9M | 2 | 1 |
| Q4 2024 | 156 | 3 | 17.12M | $424.6M | 2 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 11.81M | 10.23M | 12.13M | 12.47M | 11.04M | 8.85M | 8.48M | 7.07M |
| Andrew Spokes | 10.28M | 10.24M | 10.13M | 10.06M | 10.06M | 10.01M | 9.93M | 8.24M |
| Stanley Druckenmiller | · | 153.6K | — | — | — | — | — | — |
| Temasek | — | — | — | — | — | — | 1.81M | 1.81M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own BEAM?
In their latest 13F filings: Cathie Wood (1.66% of the portfolio, $288.6M), Andrew Spokes (1.31% of the portfolio, $251.3M), Stanley Druckenmiller (0.12% of the portfolio, $5.3M).
Who bought BEAM last quarter?
Cathie Wood (added 15%), Andrew Spokes (added 0.4%), Stanley Druckenmiller (new position). “Last quarter” is each investor's latest reported quarter.
Who sold BEAM last quarter?
Sold out entirely: Murray Stahl (was $287.9K).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Beam Therapeutics Inc (BEAM)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/BEAM/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to BEAM by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.